Related Experiment Video
Updated: Dec 23, 2025
09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.7K
Exosomes as a Multicomponent Biomarker Platform in Cancer
Valerie S LeBleu1, Raghu Kalluri2
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Trends in Cancer
|April 21, 2020
Summary
Exosomes, small extracellular vesicles, show promise as cancer biomarkers. Their detection in liquid biopsies offers a multiparameter platform for improved cancer diagnosis, prognosis, and progression monitoring.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Cancer involves complex genetic aberrations and host responses.
- Tumors exhibit dynamic cellular interplay sustaining cancer signaling.
- Extracellular vesicles (EVs), including exosomes, mediate cellular communication in cancer.
Purpose of the Study:
- To discuss the challenges and utility of exosomes as cancer biomarkers.
- To explore exosomes as multiparameter biomarker platforms for cancer detection.
Main Methods:
- Review of current research on exosome biogenesis and function.
- Analysis of exosome characteristics in liquid biopsies.
- Discussion of exosome-based detection strategies for cancer.
Main Results:
- Exosomes play a recognized role in cancer progression and therapeutic resistance.
- Exosomes are produced ubiquitously and possess unique biological features.
- Exosomes reflect heterogeneous tumor-associated biological changes.
Conclusions:
- Exosomes hold significant potential as cancer biomarkers.
- Multiparameter exosome analysis can enhance cancer diagnosis and prognosis.
- Exosomes offer a promising avenue for comprehensive cancer assessment.
